Source link : https://www.newshealth.biz/health-news/eu-regulator-backs-use-of-pfizers-gene-therapy-for-rare-bleeding-disorder/
(Reuters) – The European Medicines Agency (EMA) has recommended the use of Pfizer’s gene therapy for a rare bleeding disorder called hemophilia B, which typically requires regular infusions of a blood-clotting protein, the regulator said on Friday. The regulator has recommended granting a ‘conditional marketing authorization,’ which is for the approval of a medicine addressing […]
Author : News Health
Publish date : 2024-05-31 10:29:51
Copyright for syndicated content belongs to the linked Source.
Categories